| Literature DB >> 36001245 |
Angeliny Tamiarana Lima Tabosa1,2, Marcela Gonçalves Souza1,2, Sabrina Ferreira de Jesus1,2, Danielle Ferreira Rocha1,2, Lorena Dos Reis Pereira Queiroz1,2, Eloá Mangabeira Santos1,2, Victor Hugo Dantas Guimarães1,2, Luciano Alves de Araújo Andrade3, Sérgio Henrique Santos4,2, Alfredo Maurício Batista de Paula1,2, Paulo Eduardo Narcizo de Souza5, Lucyana Conceição Farias1,2, André Luiz Sena Guimarães6,7,8.
Abstract
Radiation therapy for head and neck squamous cell carcinoma (HNSCC) is associated with several complications. Although photobiomodulation (PBM) has radioprotective effects in normal tissue, it could also enhance the growth of neoplastic cells. Thus, the present study aimed to investigate the cellular response of oral squamous cell carcinoma with pre-exposure to low-level phototherapy before radiotherapy. SCC9, Cal-27, A431, and HaCaT cell lines were subjected to low-level light therapy and radiotherapy. The cells were treated with a single energy density (300 J/cm2) of a light-emitting diode (660 nm) prior to ionizing radiation at different doses (0, 2, 4, and 6 Gy). After 24 h, wound scratch, proliferation, clonogenic cell survival, cell death, and reactive oxygen species (ROS) analyses were performed to evaluate cell response. The cell lines pre-exposed to PBM at the analyzed dosage were radiosensitive. The treatment significantly reduced cell proliferation and clonogenic cell survival. Migration and cell death assays also revealed positive results, with the treatment group showing lower rate of migration and higher cell death than did the control group. Moreover, PBM effectively increased the intracellular levels of ROS. PBM at 300 J/cm2 is a promising radiosensitizing modality to reduce the radiation dose and avoid the intolerable side effects of radiotherapy for HNSCC, thus increasing the probability of successful treatment. However, further studies are needed to support and confirm the results.Entities:
Keywords: Head and neck cancer; Ionizing radiation; LED; Low-level light therapy; Photobiomodulation; Radiosensitization
Year: 2022 PMID: 36001245 DOI: 10.1007/s10103-022-03632-x
Source DB: PubMed Journal: Lasers Med Sci ISSN: 0268-8921 Impact factor: 2.555